TXMD
TherapeuticsMD, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$2.19
+0.46%Next report
Analyst consensus
- Next report date
- Nov 17, 2026
- EPS estimate
- -$6.13
- Revenue estimate
- $19.8M
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- $0.01
- EPS estimate
- -$6.13
- Revenue actual
- $869.0K
- Revenue estimate
- $19.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +63.5%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$6.13 | $0.01 | Beat 100.16% | $869.0K |
| May 12, 2026 | -$6.13 | $0.01 | Beat 100.16% | $724.0K |
| Mar 30, 2026 | -$6.13 | -$0.05 | Beat 99.12% | $893.0K |
| Nov 12, 2025 | — | $0.01 | — | $784.0K |
| Mar 27, 2025 | $0.04 | $0.02 | Miss -45.38% | $667.0K |
| May 10, 2024 | $0.03 | -$0.07 | Miss -333.33% | $313.0K |
| Mar 29, 2024 | -$0.13 | -$0.08 | Beat 38.46% | $502.0K |
| Nov 14, 2023 | -$0.15 | -$0.13 | Beat 13.33% | -$53.0K |
| Aug 14, 2023 | -$0.07 | -$0.24 | Miss -242.86% | $437.0K |
| May 15, 2023 | $0.06 | -$0.24 | Miss -500.00% | $416.0K |
| Nov 14, 2022 | -$2.04 | -$3.13 | Miss -53.43% | $20.9M |
| Aug 15, 2022 | -$3.04 | -$2.15 | Beat 29.28% | $28.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 17, 2026